NanoCell Therapeutics
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$4.39M
Company Overview
NanoCell Therapeutics is a biotechnology company that develops non-viral, DNA-based in vivo gene therapy platforms for the treatment of oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoCell Therapeutics Comparables
Compare NanoCell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 82% | |
| Aera Therapeutics | 82% | |
| Gilead Sciences | 82% | |
NanoCell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Seed | Jun 16, 2025 | ||||
| Grant | Jan 4, 2023 |
Key People
Founding team and executive leadership
NanoCell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eureka Network | Grant |
| Institute for Follicular Lymphoma Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 1845% MoM, from 49 to 953.
NanoCell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoCell Therapeutics's valuation, stock price, and market status.